MedPath

Analysis of Human Tear Proteins in Children

Completed
Conditions
Eye Disease
Registration Number
NCT00473278
Lead Sponsor
University of Colorado, Denver
Brief Summary

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Less than 18 years of age
  • A parent or legal guardian provide written informed consent to participate
  • Able to cooperate with tear sample collection, or a previously planned sedation for other medical purposes
Read More
Exclusion Criteria
  • Age greater than or equal to 18 years
  • Patients' parents or legal guardians who refuse to sign study consent
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proteome of Human TearsSingle Exam
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Childrens Hospital

🇺🇸

Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath